Germany-based biotech company, CatalYm, has closed an oversubscribed US$150m Series D financing. Founded in 2016 with support from Forbion and …
RESEARCH TRIANGLE PARK, N.C., July 16, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that …
In Switzerland, drug prices make a significant contribution to healthcare costs. Christian Beutler / Keystone Swiss voters have rejected the …
CordenPharma, a full-service CDMO, has announced its largest strategic investment to date with a committed spend of circa €900m (US$981m) …
Pan-European network of ophthalmological clinics, veonet, has appointed Sebastian James as group CEO, effective November 2024. He will succeed Dr …
Apeiron Biologics, an Austrian biotech company, is being acquired by US-based Ligand Pharmaceuticals for US$100m. Shareholders are also entitled to …
Medartis, a manufacturer of medical devices for the surgical fixation of bone fractures, has appointed Matthias Schupp to the position …
SIX Swiss-listed CDMO, Siegfried Group, has appointed Marcel Imwinkelried as the new CEO with effect as of September 1, 2024. …
French drugmaker Sanofi is poised to commit between 1.3 billion euros and 1.5 billion euros ($1.4 billion – $1.6 billion) …
Switzerland-based Viopas Venture Consulting (VVC), a provider of strategic, operational, business and finance advice to companies in the life sciences …